Asbestosis
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
all patients
advice on importance of not smoking
This is the most important physician intervention given the synergy between cigarettes and asbestos for increasing the risk of lung cancer.
The increased risk of lung cancer in nonsmoking asbestos workers is 5.2, in smoking nonasbestos-exposed individuals the risk is 10.8, but in smoking asbestos workers the risk of lung cancer is increased 53-fold.[25]Selikoff IJ, Seidman H. Asbestos-associated deaths among workers in the United States and Canada, 1967-1987. Ann NY Acad Sci. 1991 Dec 31;643:1-14. http://www.ncbi.nlm.nih.gov/pubmed/1809121?tool=bestpractice.com
supportive care
Treatment recommended for ALL patients in selected patient group
Antibiotics should be given if there is evidence of infection, such as change in sputum production, fever and increasing dyspnea.
Patients with evidence of obstructive airways disease should receive appropriate bronchodilator therapy.
pulmonary rehabilitation ± oxygen therapy
Treatment recommended for SOME patients in selected patient group
Pulmonary rehabilitation is designed to reduce symptoms and optimize functional status. It involves exercise training, education, nutritional intervention, and psychosocial support and is recommended by the American Thoracic Society for patients with interstitial lung disease.[31]Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013 Oct 15;188(8):e13-64. https://www.atsjournals.org/doi/full/10.1164/rccm.201309-1634ST http://www.ncbi.nlm.nih.gov/pubmed/24127811?tool=bestpractice.com [32]Rochester CL, Alison JA, Carlin B, et al. Pulmonary rehabilitation for adults with chronic respiratory disease: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2023 Aug 15;208(4):e7-26. https://www.atsjournals.org/doi/10.1164/rccm.202306-1066ST http://www.ncbi.nlm.nih.gov/pubmed/37581410?tool=bestpractice.com There is low- to moderate-quality evidence for improvements in dyspnea and quality of life for people with interstitial lung disease, and moderate-quality evidence for improvements in exercise capacity.[32]Rochester CL, Alison JA, Carlin B, et al. Pulmonary rehabilitation for adults with chronic respiratory disease: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2023 Aug 15;208(4):e7-26. https://www.atsjournals.org/doi/10.1164/rccm.202306-1066ST http://www.ncbi.nlm.nih.gov/pubmed/37581410?tool=bestpractice.com [33]Dowman L, Hill CJ, May A, et al. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2021 Feb 1;2(2):CD006322. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006322.pub4/full http://www.ncbi.nlm.nih.gov/pubmed/34559419?tool=bestpractice.com Further studies are needed to establish the optimal exercise prescription and to determine the long-term benefits.[33]Dowman L, Hill CJ, May A, et al. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev. 2021 Feb 1;2(2):CD006322. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006322.pub4/full http://www.ncbi.nlm.nih.gov/pubmed/34559419?tool=bestpractice.com
Patients with progressive fibrosis and PaO₂ of ≤55 mmHg or oxygen saturation of ≤89% are candidates for oxygen therapy.[34]Suntharalingam J, Wilkinson T, Annandale J, et al. British Thoracic Society quality standards for home oxygen use in adults. BMJ Open Respir Res. 2017 Sep 18;4(1):e000223. https://www.doi.org/10.1136/bmjresp-2017-000223 http://www.ncbi.nlm.nih.gov/pubmed/29018527?tool=bestpractice.com
Oxygen therapy improves exercise tolerance and reduces the risk of developing pulmonary hypertension and cor pulmonale.
pleural decortication or lung transplant
A patient may develop diffuse pleural thickening of sufficient extent that pleural decortications should be considered. However, this is very rare and pleural thickening does not usually require treatment.
Patients with end-stage respiratory failure (PaO₂ <60 mmHg despite oxygen therapy) due to parenchymal disease are potential candidates for lung transplants.[35]Alalawi R, Whelan T, Bajwa RS. Lung transplantation and interstitial lung disease. Curr Opin Pulm Med. 2005 Sep;11(5):461-6. http://www.ncbi.nlm.nih.gov/pubmed/16093823?tool=bestpractice.com
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer